Publication: Assessment of synergistic interactions of danofloxacin and orbifloxacin against quinolone-resistant Escherichia coli isolated from animals by the checkerboard and time-kill methods
dc.contributor.buuauthor | Cengiz, Murat | |
dc.contributor.buuauthor | Şahintürk, Pınar | |
dc.contributor.department | Veterinerlik Fakültesi | |
dc.contributor.department | Farmakoloji ve Toksikoloji Ana Bilim Dalı | |
dc.contributor.researcherid | ABE-5935-2020 | |
dc.contributor.scopusid | 16635026700 | |
dc.contributor.scopusid | 55342852700 | |
dc.date.accessioned | 2023-05-09T10:52:38Z | |
dc.date.available | 2023-05-09T10:52:38Z | |
dc.date.issued | 2013-10 | |
dc.description.sponsorship | European Cooperation in Science and Technology (COST) (BM0701 ATENS') | |
dc.identifier.citation | Cengiz, M. ve Şahintürk, P. (2013). “Assessment of synergistic interactions of danofloxacin and orbifloxacin against quinolone-resistant Escherichia coli isolated from animals by the checkerboard and time-kill methods”. Journal of Antibiotics, 66(10), 629-631. | |
dc.identifier.endpage | 631 | |
dc.identifier.issn | 0021-8820 | |
dc.identifier.issue | 10 | |
dc.identifier.pubmed | 23778116 | |
dc.identifier.scopus | 2-s2.0-84886771418 | |
dc.identifier.startpage | 629 | |
dc.identifier.uri | https://doi.org/10.1038/ja.2013.62 | |
dc.identifier.uri | http://hdl.handle.net/11452/32595 | |
dc.identifier.volume | 66 | |
dc.identifier.wos | 000326287600008 | |
dc.indexed.wos | SCIE | |
dc.language.iso | en | |
dc.publisher | Springernature | |
dc.relation.journal | Journal of Antibiotics | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
dc.relation.tubitak | TOVAG-110O478 | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Biotechnology & applied microbiology | |
dc.subject | Immunology | |
dc.subject | Microbiology | |
dc.subject | Pharmacology & pharmacy | |
dc.subject | Danofloxacin | |
dc.subject | Escherichia coli | |
dc.subject | Orbifloxacin | |
dc.subject | Synergism | |
dc.subject | In-vitro | |
dc.subject | Floroquinolone resistance | |
dc.subject | Pseudomonas-aeruginosa | |
dc.subject | Ciprofloxacin | |
dc.subject | Enrofloxacin | |
dc.subject | Combination | |
dc.subject | Mevhanisms | |
dc.subject.emtree | Danofloxacin | |
dc.subject.emtree | Orbifloxacin | |
dc.subject.emtree | Antibiotic resistance | |
dc.subject.emtree | Article | |
dc.subject.emtree | Bacterial strain | |
dc.subject.emtree | Bactericidal activity | |
dc.subject.emtree | Bacterium isolate | |
dc.subject.emtree | Bacterium isolation | |
dc.subject.emtree | Drug efficacy | |
dc.subject.emtree | Drug potentiation | |
dc.subject.emtree | Escherichia coli | |
dc.subject.emtree | Minimum inhibitory concentration | |
dc.subject.emtree | Nonhuman | |
dc.subject.emtree | Priority journal | |
dc.subject.emtree | Quinolone resistant Escherichia coli | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Anti-bacterial agents | |
dc.subject.mesh | Ciprofloxacin | |
dc.subject.mesh | Drug resistance, bacterial | |
dc.subject.mesh | Drug synergism | |
dc.subject.mesh | Drug therapy, combination | |
dc.subject.mesh | Escherichia coli | |
dc.subject.mesh | Fluoroquinolones | |
dc.subject.mesh | Microbial sensitivity tests | |
dc.subject.mesh | Quinolones | |
dc.subject.scopus | Escherichia Coli; Plasmids; Enterobacteriaceae | |
dc.subject.wos | Biotechnology & applied microbiology | |
dc.subject.wos | Immunology | |
dc.subject.wos | Microbiology | |
dc.subject.wos | Pharmacology & pharmacy | |
dc.title | Assessment of synergistic interactions of danofloxacin and orbifloxacin against quinolone-resistant Escherichia coli isolated from animals by the checkerboard and time-kill methods | |
dc.type | Article | |
dc.wos.quartile | Q3 | |
dc.wos.quartile | Q4 (Immunology) | |
dspace.entity.type | Publication | |
local.contributor.department | Veterinerlik Fakültesi/Farmakoloji ve Toksikoloji Ana Bilim Dalı | |
local.indexed.at | Scopus | |
local.indexed.at | WOS |
Files
License bundle
1 - 1 of 1
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: